Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time

Author:

Rodebaugh Thomas L1ORCID,Frumkin Madelyn R1,Reiersen Angela M2,Lenze Eric J2,Avidan Michael S3,Miller J Philip4,Piccirillo Jay F5,Zorumski Charles F2,Mattar Caline6

Affiliation:

1. Department of Psychological and Brain Sciences, Washington University in St Louis, St Louis, Missouri, USA

2. Department of Psychiatry, Washington University School of Medicine (WUSM), St Louis, Missouri, USA

3. Department of Anesthesiology, WUSM, St Louis, Missouri, USA

4. Institute for Informatics, Division of Biostatistics, WUSM, St Louis, Missouri, USA

5. Department of Otolaryngology, WUSM, St Louis, Missouri, USA

6. Department of Internal Medicine, Division of Infectious Diseases, WUSM, St Louis, Missouri, USA

Abstract

Abstract Background The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration. Methods One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles. Results Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea. Conclusions The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration.

Funder

Taylor Family Institute for Innovative Psychiatric Treatment at Washington University

COVID-19 Early Treatment Fund

Center for Brain Research in Mood Disorders at Washington University

Bantly Foundation

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Reference22 articles.

1. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019;Lechien;J Intern Med,2020

2. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review;Wiersinga;JAMA,2020

3. Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers;Liu;J Intern Med

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3